Flipkart to acquire Bengaluru-based online pharmacy startup Pharmallama

Share via:

Flipkart is reportedly close to acquiring Bengaluru-based online pharmacy startup Pharmallama, which is run by its parent company Mera Dawai Pvt Ltd.

Pharmallama operates a mobile app that provides medication delivery to customers’ homes. Pharmallama delivers medications after a customer uploads a prescription to the company’s app. The medicines are then packaged in various presorted parcels arranged by date, time, and dosages. Once the startup confirms the medications with customers, they are delivered. If the deal goes through, Pharmallama will be Flipkart’s second acquisition in the epharmacy space, following the November 2021 acquisition of Kolkata-based healthtech startup SastaSundar Marketplace.

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Flipkart to acquire Bengaluru-based online pharmacy startup Pharmallama

Flipkart is reportedly close to acquiring Bengaluru-based online pharmacy startup Pharmallama, which is run by its parent company Mera Dawai Pvt Ltd.

Pharmallama operates a mobile app that provides medication delivery to customers’ homes. Pharmallama delivers medications after a customer uploads a prescription to the company’s app. The medicines are then packaged in various presorted parcels arranged by date, time, and dosages. Once the startup confirms the medications with customers, they are delivered. If the deal goes through, Pharmallama will be Flipkart’s second acquisition in the epharmacy space, following the November 2021 acquisition of Kolkata-based healthtech startup SastaSundar Marketplace.

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

10 Visionary Doctors Redefining the Future of Healthcare

Mumbai (Maharashtra) , July 1:  Meet 10 visionary doctors transforming...

Two Chinese chip firms plan $1.7 billion IPOs, bet...

Two Chinese artificial intelligence chip startups are seeking...

Google Pixel 10 Pro and Pro XL specs leak...

With Google’s official Pixel 10 series launch expected...

Popular

Upcoming Events

Grammarly acquires email startup Superhuman in AI platform push

Grammarly has acquired email efficiency tool Superhuman as...

Songscription launches an AI-powered ‘Shazam for sheet music’

A small company called Songscription launched last week...

Baidu appoints Haijian He as CFO

SynopsisJunjie He, who was serving as the interim...
ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq ASDFq referal referal referal referal referal referal referal referal referal referal referal referal referal referal referal referal referal referal referal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal refersal almydannews almydannews almydannews almydannews almydannews almydannews almydannews almydannews almydannews almydannews refersal refersal refersal refersal refersal refersal
IPTV IPTV IPTV IPTV IPTV IPTV IPTV